An Oncology Nurse’s Guide to the FDA Cancer Drug Approval Process

The rapid advancements in oncology treatments—with new approvals in therapies like small molecules, biologics, biosimilars, and cellular therapies coming nearly every month—can be challenging for any nurse to keep up with, let alone truly understand the nuances of those approvals. As new discoveries unfold, the U.S. Food and Drug Administration oversees the lengthy and multifaceted journey a drug or biologic takes from the laboratory to the patient. The ultimate goal of the many steps is to balance providing access to the latest treatments with ensuring patient safety.

This article was produced by ONS and is paid for by PDI Healthcare.